Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database - PubMed (original) (raw)
Multicenter Study
Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database
M J Fine et al. Am J Med. 1993 Feb.
Abstract
Purpose: Our purpose was to validate a previously developed pneumonia-specific prognostic index in a large, multicenter population.
Patients and methods: We developed a pneumonia-specific prognostic index in a prospective, multicenter study of 346 patients with clinical and radiographic evidence of pneumonia admitted to 3 Pittsburgh hospitals (the derivation cohort), and validated the index in 14,199 patients with a principal ICD-9-CM diagnosis of pneumonia admitted to 78 hospitals in the 1989 MedisGroups Comparative Hospital Database (the validation cohort). The prognostic index classified patients into five ordered risk classes based on six predictors of mortality: age greater than 65 years, pleuritic chest pain, a vital sign abnormality, altered mental status, neoplastic disease, and high-risk pneumonia etiology. Each patient in the validation cohort was assigned to a risk class by obtaining values for the index's six predictors in the MedisGroups population. The performance of the prognostic index in the derivation and validation cohorts was assessed by comparing hospital mortality rates within each of the index's five prognostic risk classes.
Results: The hospital mortality rate was 13.0% in the derivation cohort, and 11.1% in the validation cohort (p = 0.26). The agreement in the risk class-specific mortality rates was striking with the exception of class V: in class I, mortality was 0% in the derivation cohort versus 1% in the validation cohort; in class II, 0% versus 1.1%; class III, 10.9% versus 8.6%; class IV, 21.8% versus 26.2%; and class V, 73.7% versus 37.7%. There were no statistically significant differences in mortality rates within the first four risk classes, which represented the vast majority of patients in the derivation (94%) as well as the validation (98%) cohorts.
Conclusions: These data support the generalizability of a pneumonia-specific prognostic index. This index, which performs exceptionally well in classifying low-risk patients, may help physicians identify patients with community-acquired pneumonia who could safely be managed in the ambulatory setting, or if hospitalized, the patients that could be treated with abbreviated inpatient care.
Similar articles
- Prognosis of patients hospitalized with community-acquired pneumonia.
Fine MJ, Orloff JJ, Arisumi D, Fang GD, Arena VC, Hanusa BH, Yu VL, Singer DE, Kapoor WN. Fine MJ, et al. Am J Med. 1990 May;88(5N):1N-8N. Am J Med. 1990. PMID: 2195886 Clinical Trial. - Severe community-acquired pneumonia in ICUs: prospective validation of a prognostic score.
Leroy O, Georges H, Beuscart C, Guery B, Coffinier C, Vandenbussche C, Thevenin D, Beaucaire G. Leroy O, et al. Intensive Care Med. 1996 Dec;22(12):1307-14. doi: 10.1007/BF01709543. Intensive Care Med. 1996. PMID: 8986478 - A prognostic rule for elderly patients admitted with community-acquired pneumonia.
Conte HA, Chen YT, Mehal W, Scinto JD, Quagliarello VJ. Conte HA, et al. Am J Med. 1999 Jan;106(1):20-8. doi: 10.1016/s0002-9343(98)00369-6. Am J Med. 1999. PMID: 10320113 - Outcome of nursing home-acquired pneumonia: derivation and application of a practical model to predict 30 day mortality.
Naughton BJ, Mylotte JM, Tayara A. Naughton BJ, et al. J Am Geriatr Soc. 2000 Oct;48(10):1292-9. doi: 10.1111/j.1532-5415.2000.tb02604.x. J Am Geriatr Soc. 2000. PMID: 11037018 - Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia.
España PP, Capelastegui A, Quintana JM, Bilbao A, Diez R, Pascual S, Esteban C, Zalacaín R, Menendez R, Torres A. España PP, et al. J Infect. 2010 Feb;60(2):106-13. doi: 10.1016/j.jinf.2009.11.013. Epub 2009 Dec 2. J Infect. 2010. PMID: 19961875 Review.
Cited by
- Development of a new prognostic index PNPI for prognosis prediction of CKD patients with pneumonia at hospital admission.
Cai XY, Fan JH, Cheng YC, Ge SW, Xu G. Cai XY, et al. Front Med (Lausanne). 2023 Aug 10;10:1135586. doi: 10.3389/fmed.2023.1135586. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37636568 Free PMC article. - Eosinopenia Predicting Long-term Mortality in Hospitalized Acute Exacerbation of COPD Patients with Community-acquired Pneumonia-A Retrospective Analysis.
Mao Y, Qian Y, Sun X, Li N, Huang H. Mao Y, et al. Int J Chron Obstruct Pulmon Dis. 2021 Dec 30;16:3551-3559. doi: 10.2147/COPD.S347948. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 35002227 Free PMC article. - Risk analysis for the reintroduction and transmission of measles in the post-elimination period in the Americas.
Lemos DRQ, Franco AR, de Oliveira Garcia MH, Pastor D, Bravo-Alcantara P, de Moraes JC, Domingues C, Pamplona de Goes Cavalcanti L. Lemos DRQ, et al. Rev Panam Salud Publica. 2017 Dec 20;41:e157. doi: 10.26633/RPSP.2017.157. eCollection 2017. Rev Panam Salud Publica. 2017. PMID: 31391839 Free PMC article. - Sequential organ failure assessment score is an excellent operationalization of disease severity of adult patients with hospitalized community acquired pneumonia - results from the prospective observational PROGRESS study.
Ahnert P, Creutz P, Horn K, Schwarzenberger F, Kiehntopf M, Hossain H, Bauer M, Brunkhorst FM, Reinhart K, Völker U, Chakraborty T, Witzenrath M, Löffler M, Suttorp N, Scholz M; PROGRESS Study Group. Ahnert P, et al. Crit Care. 2019 Apr 4;23(1):110. doi: 10.1186/s13054-019-2316-x. Crit Care. 2019. PMID: 30947753 Free PMC article. - Mortality Predictive Scores for Community-Acquired Pneumonia in Children.
Arbo A, Lovera D, Martínez-Cuellar C. Arbo A, et al. Curr Infect Dis Rep. 2019 Mar 5;21(3):10. doi: 10.1007/s11908-019-0666-9. Curr Infect Dis Rep. 2019. PMID: 30834468 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical